With a lot of good will (that I absolutely don't have at the moment), one could argue that much better offers are coming or a complete BO.

The thing is: I've always thought about a HIV-deal as a means to have enough funding to develop leronlimab as a immuno-oncology drug and keep cancer for ourselves, since the value of cancer, if proven, is astronomical...

And I don't think that we will be bought for double-digits at this point, sorry.

So, pausing on the deal doesn't really make sense to me...